Product Images Bevespi Aerosphere

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 26 images provide visual information about the product associated with Bevespi Aerosphere NDC 0310-4600 by Astrazeneca Pharmaceuticals Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - Mean Change from Baseline in FEV1 over Time on Day 14 (MITT Population) - bevespi aerosphere 03

Figure 1 - Mean Change from Baseline in FEV1 over Time on Day 14 (MITT Population) - bevespi aerosphere 03

This data presents the adjusted mean change from baseline in FEV over time (in hours) for various dosages and types of inhalers (GP MDI 18mcg, GP MDI 9mcg, GP MDI 4.6 mcg, GP MDI 24 mcg, GP MDI 1.2 mcg, GP MDI 0.6 mcg, and Placebo).*

Figure 2 - Mean Change from Baseline in FEV1 over Time on Day 1 - bevespi aerosphere 04

Figure 2 - Mean Change from Baseline in FEV1 over Time on Day 1 - bevespi aerosphere 04

Figure 3 - Mean Change from Baseline in FEV1 over Time at Day 1 and Week 12 (Trial 1) Day 1 - bevespi aerosphere 05

Figure 3 - Mean Change from Baseline in FEV1 over Time at Day 1 and Week 12 (Trial 1) Day 1 - bevespi aerosphere 05

This is a graph displaying the adjusted mean change from baseline in FEV (forced expiratory volume) over time (in hours) for four different treatments: BEVESPI AEROSPHERE, GPMDI 18 mcg, FF MDI 9.6 mcg, and Placebo. The x-axis represents time while the y-axis represents the adjusted mean change in FEV (in 350 g units).*

Week 12 - bevespi aerosphere 06

Week 12 - bevespi aerosphere 06

This appears to be a graph displaying the adjusted mean change from baseline in some variable over time (in hours) for four different treatments, including "BEVESPI AEROSPHERE," "GPMDI 18 mcg," "FFMDI 9.6 mcg," and "Placebo." Without additional context or information, it is not possible to determine what the variable being measured is.*

PRINCIPAL DISPLAY PANEL NDC 0310-4600-12 Bevespi Aerosphere 9 mcg/4.8 mcg per inhalation 120 inhalations for oral inhalation only - bevespi aerosphere 1A

PRINCIPAL DISPLAY PANEL NDC 0310-4600-12 Bevespi Aerosphere 9 mcg/4.8 mcg per inhalation 120 inhalations for oral inhalation only - bevespi aerosphere 1A

image 01

image 01

The text provides a visual representation of a medical device, likely an inhaler, from the side view. The device consists of a canister, an actuator, and a mouthpiece, with a dose indicator also visible. The purpose and details of the device are not provided in the text.*

image 02

image 02

The text provides a description of Figure 2a, 2b, and 2c showing the number of puffs - 120, 110, and 100 respectively. It is not clear what the figures are related to without further information.*

image 03

image 03

image 04

image 04

image 05

image 05

image 06

image 06

image 07

image 07

image 08

image 08

image 09

image 09

image 10

image 10

image 11

image 11

image 12

image 12

image 13

image 13

image 14

image 14

image 15

image 15

image 16

image 16

image 17

image 17

image 18

image 18

image 19

image 19

image 20

image 20

image 21

image 21

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.